Early Pulmonary Rehabilitation Following Acute COPD Exacerbation

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2007 by King's College Hospital NHS Trust.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
British Lung Foundation
Information provided by:
King's College Hospital NHS Trust
ClinicalTrials.gov Identifier:
NCT00557115
First received: November 9, 2007
Last updated: NA
Last verified: November 2007
History: No changes posted
  Purpose

The principal aim of the study is to evaluate whether attendance at an exercise training and education programme (known as pulmonary rehabilitation) shortly following hospital discharge can lead to a reduction in exacerbations and improvement in exercise capacity and quality of life in patients with chronic obstructive pulmonary disease.


Condition Intervention Phase
COPD
Other: Early pulmonary rehabilitation (EPR)
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Early Pulmonary Rehabilitation (PR) Following Hospitalisation For Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)

Resource links provided by NLM:


Further study details as provided by King's College Hospital NHS Trust:

Primary Outcome Measures:
  • Non-outpatient COPD related hospital attendance (A+E attendance, inpatient admission or death) [ Time Frame: 3-months ]

Secondary Outcome Measures:
  • Disease specific quality of life (CRDQ and SGRQ) [ Time Frame: 3 months and 1-year ]
  • Maximal walking capacity (ISW)and endurance walking capacity (ESW) [ Time Frame: 3-months and 1-year ]
  • Weight and fat free mass (electrical bioimpedance) [ Time Frame: 3-months and 1-year ]
  • Quadriceps muscle strength (volitional and non-volitional) [ Time Frame: 3-months and 1-year ]
  • Cost-effectiveness (Index derived from EQ-5D) [ Time Frame: 3-months and 1-year ]

Estimated Enrollment: 60
Study Start Date: January 2006
Estimated Study Completion Date: January 2009
Arms Assigned Interventions
No Intervention: Usual Care
Usual Care (UC): usual follow up care post acute COPD exacerbation
Experimental: EPR
Early pulmonary rehabilitation (EPR): pulmonary rehabilitation commenced within 1-week of hospital discharge from an acute COPD exacerbation
Other: Early pulmonary rehabilitation (EPR)
Multidisciplinary exercise programme in the format of standard pulmonary rehabilitation. Consists of 2 supervised exercise and educations sessions per week for up to 16 sessions within 3-months. Participants are encouraged to keep an exercise diary at perform at least one exercise session at home unsupervised.

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   40 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All patients admitted to King's College Hospital with a clinical diagnosis of acute exacerbation of COPD. Patients with radiological and microbiological evidence of pneumonia with co−existing COPD will also be included.

Exclusion Criteria:

  • Significant co−morbidity that could limit exercise training & testing: Patients unable to walk due to a comorbid neuromuscular or rheumatological condition; patients with severe sensory and cognitive impairment; patients with unstable angina or aortic valve disease in which exercise could be dangerous.
  • Attendance at a pulmonary rehabilitation programme in the preceding year.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00557115

Contacts
Contact: John Moxham, MD FRCP 02032999000 ext 3185 julie.fuller@kch.nhs.uk
Contact: Mike I Polkey, PhD FRCP 0207 351 8029 m.polkey@rbht.nhs.uk

Locations
United Kingdom
Basildon University Hospital Recruiting
Basildon, Essex, United Kingdom
Contact: Bernard Yung, MD MRCP    01268 598688    Dr.Yung@btuh.nhs.uk   
King's College Hospital Recruiting
London, United Kingdom, SE5 9RJ
Sub-Investigator: John M Seymour, MA MRCP         
St Thomas' Hospital Recruiting
London, United Kingdom, SE1 7EH
Contact: Nick Hart, PhD MRCP    02071889123    nicholas.hart@gstt.nhs.uk   
Sponsors and Collaborators
King's College Hospital NHS Trust
British Lung Foundation
Investigators
Principal Investigator: John Moxham, MD FRCP King's College London
  More Information

No publications provided by King's College Hospital NHS Trust

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00557115     History of Changes
Other Study ID Numbers: 05/Q0703/093, BLF PO4/8
Study First Received: November 9, 2007
Last Updated: November 9, 2007
Health Authority: United Kingdom: Medicines and Healthcare Products Regulatory Agency

Keywords provided by King's College Hospital NHS Trust:
Quality of life
Quadriceps
Muscle
Exacerbation

Additional relevant MeSH terms:
Pulmonary Disease, Chronic Obstructive
Lung Diseases, Obstructive
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on April 22, 2014